{
    "code": 0,
    "data": [
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q3 FY 26",
            "news_id": "1ee409e3-0c03-4ab5-877c-8be74f2da5fa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c371bec7-ba30-43fc-831f-cf12647c167a.pdf",
            "news_date": "2026-02-10 12:55:35",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Financial Results for the quarter and nine months ended December 31 2025",
            "news_id": "e54c23b1-a0c6-4aa5-90c8-c908fcc90836",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=672dd8eb-5635-41b0-b0b8-2e277ec67374.pdf",
            "news_date": "2026-02-09 20:10:40",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2 FY 26 Earnings Conference Call.",
            "news_id": "9f15fe40-7d51-4f5c-9d14-29bf6fad72e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=085f5cd1-1ce8-443f-8f57-58a02d1d7258.pdf",
            "news_date": "2025-11-17 17:29:06",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q2 FY 26",
            "news_id": "7c30b0e8-996b-4047-afa1-ed9ca484773f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46d58674-e6a3-408b-8347-9ef5132efe9b.pdf",
            "news_date": "2025-11-11 08:18:15",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Half Year Ended September 30 2025",
            "news_body": "Please find enclosed.",
            "news_id": "26b00cd9-d4fe-4ca3-8487-8ddefe3fd682",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=121daa9d-5c82-4fe8-b1ff-6e96e46485c8.pdf",
            "news_date": "2025-11-09 16:27:27",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed",
            "news_id": "f29185fd-5527-44d3-a98d-b573a03a1111",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfbef63c-c610-46a5-97e5-f2e40eb3bff2.pdf",
            "news_date": "2025-09-23 19:53:41",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript for Q1 FY26 Earnings Conference Call",
            "news_id": "9cb29a46-9f4b-4ef0-9f23-234ccaf622ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=913c9018-5c3a-45aa-807f-ee7a59e50b76.pdf",
            "news_date": "2025-08-20 13:41:23",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q1 FY 26",
            "news_id": "cdf0c612-b96a-44b9-84c5-67905e888338",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4a5587f-7ee8-4fb7-8ee5-07d93610c2a8.pdf",
            "news_date": "2025-08-13 12:46:36",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter Ended June 30 2025",
            "news_body": "Please find enclosed.",
            "news_id": "0d13fab0-57d0-45bf-9d11-6406d8ff43cb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0062c62b-b124-472a-8148-baa7a1f61e66.pdf",
            "news_date": "2025-08-12 19:24:20",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q4/H2 FY25 Earnings Conference Call",
            "news_id": "bc7925cf-1e95-46e1-81b4-a8a7618b946b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7381a766-ad0c-4780-a1cc-833b7bee3c29.pdf",
            "news_date": "2025-05-16 14:39:09",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q4 FY 25",
            "news_id": "509a54d5-61b6-41c6-95e7-89eaea01c61d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df45d866-44c7-4002-af15-877424037137.pdf",
            "news_date": "2025-05-12 12:27:37",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Financial Year Ended 31.03.2025",
            "news_body": "Outcome of the Board Meeting and Results for the financial year ended 31.03.2025",
            "news_id": "3cf0db59-f410-4a2b-a71e-640a7f155add",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a152e817-846d-4623-ab63-d7cbabafeb05.pdf",
            "news_date": "2025-05-10 19:20:26",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q3/9M Earnings Conference call",
            "news_id": "4e52d4bb-1c00-403c-bc98-ee23278e3dbf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=691228af-f2ae-415b-9a46-f5b6137b6a03.pdf",
            "news_date": "2025-02-12 16:39:48",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Quarter ended December 31 2024",
            "news_id": "5719b08e-a0ab-49a7-8d57-97926e7d0095",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ded98d2-7458-423b-ba41-f7de69b66199.pdf",
            "news_date": "2025-02-06 16:42:01",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter Ended December 31 2024",
            "news_body": "Financials Results for Quarter ended December 31 2024",
            "news_id": "b2c91e19-9829-4175-a3c3-1b14d83c644e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7575e0ec-593a-4389-b0a9-19feb368edea.pdf",
            "news_date": "2025-02-05 19:16:50",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2/H1 FY 25 Earnings conference call",
            "news_id": "99b1e686-b1b6-4e29-9bdf-9288db52f9d2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2da4905-4ad1-46bd-8d29-2b74ca8afda4.pdf",
            "news_date": "2024-11-04 17:08:18",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter and half year ended September 30, 2024",
            "news_id": "99ea1675-3464-44c0-9626-f0ba71401ffc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed8a6d03-5e28-4ac8-87d2-29bddedd0ad6.pdf",
            "news_date": "2024-10-28 16:19:52",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1 FY 25 Earnings Conference Call",
            "news_id": "3fdfdb0b-f736-4ea9-abcc-cd7750d01140",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ae85bac-cde9-46c5-8997-87a988f6e0af.pdf",
            "news_date": "2024-08-09 15:07:32",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation made at the 5th Annual General Meeting",
            "news_id": "be7b4d49-fb0e-4fab-b4e8-e18e6c4e6c6e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a24dcd5f-351c-4b14-9722-b5d8b340a486.pdf",
            "news_date": "2024-08-07 15:59:23",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q1 FY 25 Investor Presentation",
            "news_id": "9441e56b-0973-4d37-a03d-7e2c8b393b25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abb5aacd-3fd1-478d-b77e-874b53afaccc.pdf",
            "news_date": "2024-08-05 22:58:40",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "Financial Results for the Quarter ended June 30, 2024",
            "news_id": "454c18cd-387d-4bbe-b6ed-a778424b5678",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69c96790-269c-414a-ab77-806aeb74fe28.pdf",
            "news_date": "2024-08-05 15:46:59",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q4 FY 24 Earnings Conference Call",
            "news_id": "5c031c55-1c76-42f8-87a8-d4805066a3a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53d2104f-90fd-42a1-947c-3f924a2a6618.pdf",
            "news_date": "2024-05-17 18:21:42",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q4 FY 24 /FY 24 Investor Presentation",
            "news_id": "da5e6f1e-f6d4-44a6-a2da-e0884cbdb6a5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb4b71f5-f003-4840-b149-6f1a759025b6.pdf",
            "news_date": "2024-05-15 10:26:04",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financials For The Year Ended March 31, 2024",
            "news_body": "Audited Financial Results for the quarter and year ended March 31, 2024.",
            "news_id": "1280d4c2-e570-4049-b8b4-99cc46eb312f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7be682ba-c3f2-464f-8eb1-198eb09a09f7.pdf",
            "news_date": "2024-05-13 17:37:49",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "9f333b44-f07f-4b3f-b789-6b9680a89912",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0346392-c27d-4b04-bd71-73e3d122cfe3.pdf",
            "news_date": "2024-05-13 17:27:35",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q3 FY24 Earnings conference call",
            "news_id": "91b9fdb1-2173-4cc6-a19b-dbb711a132b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7b4e7b9-3254-425b-befd-c132c7186e6e.pdf",
            "news_date": "2024-02-13 15:42:52",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 FY24 Investor Presentation",
            "news_id": "889c59ae-6194-494e-ba6e-8bfc432a9c6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d586692-fd79-4de0-b188-e4bb9a3a3ab2.pdf",
            "news_date": "2024-02-08 15:46:53",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Audited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2023",
            "news_id": "6cb15cd2-5bf3-46c8-ad95-5c3df7c806aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9152347-fd1f-400f-9257-c4b1d28fbb39.pdf",
            "news_date": "2024-02-07 16:42:18",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call for Q2 FY24 Financial Results held on November 9, 2023",
            "news_id": "fb5202a0-4f09-4093-8962-515748d161a9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c72a03d1-5884-456a-ab15-09a439124b33.pdf",
            "news_date": "2023-11-13 22:41:06",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference Call of Financial Results for Q2/ H1 FY24",
            "news_id": "51299c1e-58c8-44df-8208-e042ba1bebff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72036700-355e-42f7-bac5-5b0f29b93386.pdf",
            "news_date": "2023-11-09 21:39:23",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q2 FY24 Results Presentation",
            "news_id": "fd0f2e9d-3a2f-4563-bd32-a3bf26f986ae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a85ec1f8-fe5d-4878-b428-1097714d7a3a.pdf",
            "news_date": "2023-11-08 20:29:30",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Financial Results for the quarter and half year ended September 30, 2023",
            "news_id": "9190020a-cbfa-4486-9c2f-934658184012",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39f61e20-26a8-4287-ac71-90d8abb7dc2a.pdf",
            "news_date": "2023-11-07 18:39:14",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to Shareholders of the Company at the 4th Annual General Meeting",
            "news_id": "d037fb5c-eee6-4e4c-bbdc-18cccc450890",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de454294-e7e3-4cec-86bf-36b4d763e32f.pdf",
            "news_date": "2023-09-14 16:52:36",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call held on August 10, 2023 on the Q1 FY24 Results",
            "news_id": "0818a494-316f-46b5-9265-ad78cabefb88",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=952fd5aa-2c88-42e5-b07f-bd0624195579.pdf",
            "news_date": "2023-08-16 11:16:51",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors/ Analyst Quarterly Earnings Call on the Financial Results of the Company for the Quarter ended June 30, 2023.",
            "news_id": "1a0c970d-d97a-4627-bf7c-15473f355f39",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cfa6d16-1c74-4758-9151-23483a941121.pdf",
            "news_date": "2023-08-10 22:19:09",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q1 FY24 Results Presentation of the Company",
            "news_id": "789079ed-b69f-4964-b3ab-78a7d09a9553",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f34ff8e9-a28c-4eca-9e94-f657ad90076e.pdf",
            "news_date": "2023-08-10 15:28:38",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2023.",
            "news_id": "0877b4ac-68b8-462f-9554-72500b33a48a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=741afc91-e619-4d30-993c-cd8b5849852e.pdf",
            "news_date": "2023-08-05 15:59:06",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Outcome of the Board Meeting held on Saturday, August 05, 2023.",
            "news_id": "c3ae1f75-e123-4b01-b4b6-45d1e7bd243e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a6ba501-3be9-4bb3-922d-459ee14d288d.pdf",
            "news_date": "2023-08-05 15:52:42",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith Analyst Presentation of the Company.",
            "news_id": "cd483766-0a6a-44f3-9c4a-6d8af9f968a7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92dd9da5-2e7d-4944-8a25-7bdb948e40cb.pdf",
            "news_date": "2023-06-26 16:03:14",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results_Financial Results For March 31,2023",
            "news_body": "Audited Financial Results (Standalone and Consolidated) for Quarter and Year Ended March 31, 2023.",
            "news_id": "1256e66e-4edb-4d71-b67c-0749605181bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a6adeb3-b136-4687-aae2-2773e84da541.pdf",
            "news_date": "2023-05-12 19:09:14",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIPHARM",
            "disp": "Aarti Pharma Labs",
            "bse_code": 543748,
            "isin": "INE0LRU01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Statements For The Nine Months Ended December 31, 2022",
            "news_body": "Financial Statements for the nine months ended December 31, 2022<BR>",
            "news_id": "b7ad89d8-57b7-4da4-b95a-00bfa673470d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bddf2178-3021-45a6-b0e9-9e2b393f23fc.pdf",
            "news_date": "2023-02-14 17:22:54",
            "seo": "aarti-pharma-labs-ltd",
            "ltp": 749.85,
            "ch": -14.549999999999955,
            "pch": -1.903453689167969,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 13868,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}